Notably, paclitaxel itself can induce GBP2 expression, and GBP2 knockout in chronic myeloid leukemia cells significantly attenuates paclitaxel -induced apoptosis (4). This evidence concerns the gene GBP2 and chronic myelogenous leukemia, BCR-ABL1 positive.